Burning Rock Biotech Limited
BNR
$9.02
$0.010.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 72.50M | 71.70M | 70.95M | 70.60M | 72.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.50M | 71.70M | 70.95M | 70.60M | 72.75M |
| Cost of Revenue | 20.67M | 21.33M | 22.19M | 22.80M | 23.81M |
| Gross Profit | 51.83M | 50.38M | 48.76M | 47.80M | 48.95M |
| SG&A Expenses | 52.53M | 62.87M | 74.92M | 88.56M | 89.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 101.84M | 116.48M | 132.26M | 151.21M | 157.37M |
| Operating Income | -29.34M | -44.78M | -61.31M | -80.61M | -84.62M |
| Income Before Tax | -32.25M | -47.33M | -59.08M | -78.21M | -81.99M |
| Income Tax Expenses | 823.80K | 818.10K | 227.70K | 261.70K | 299.00K |
| Earnings from Continuing Operations | -33.07 | -48.14 | -59.31 | -78.48 | -82.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.07M | -48.14M | -59.31M | -78.48M | -82.29M |
| EBIT | -29.34M | -44.78M | -61.31M | -80.61M | -84.62M |
| EBITDA | -16.66M | -29.29M | -43.05M | -62.77M | -67.02M |
| EPS Basic | -32.04 | -46.82 | -57.83 | -76.60 | -80.34 |
| Normalized Basic EPS | -0.75 | -1.67 | -2.69 | -3.86 | -5.00 |
| EPS Diluted | -32.04 | -46.82 | -57.83 | -76.60 | -80.34 |
| Normalized Diluted EPS | -0.75 | -1.67 | -2.69 | -3.86 | -5.00 |
| Average Basic Shares Outstanding | 41.68M | 41.17M | 41.08M | 40.99M | 40.97M |
| Average Diluted Shares Outstanding | 4.17M | 4.12M | 4.11M | 4.10M | 4.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |